We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

4 hedge funds and large institutions have $41.4M invested in Plus Therapeutics in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

3% more capital invested

Capital invested by funds: $40.2M → $41.4M (+$1.2M)

88% less call options, than puts

Call options by funds: $52K | Put options by funds: $449K

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$52K
Puts
$449K
Net Calls
-$397K
Net Calls Change
-$33K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$6.73M

Top Sellers

Rank Fund Capital Flow
1
Allianz Asset Management
Allianz Asset Management
Germany
-$517K
2
DCM
Driehaus Capital Management
Illinois
-$117K
3
EEG
E.E. Geduld
-$68K
4
PPA
Parametric Portfolio Associates
Washington
-$29K
5
PA
Profund Advisors
Maryland
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$5.97M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.61M – – –
SM
3
Sabby Management
Florida
$4.29M +$6.73M +1 New
BFA
4
BlackRock Fund Advisors
California
$3.97M – – –
GCM
5
Goldman Capital Management
New York
$2.4M – – –
State Street
6
State Street
Massachusetts
$2.14M – – –
MCM
7
Marathon Capital Management
Maryland
$2.12M – – –
PCM
8
Perkins Capital Management
Minnesota
$1.85M – – –
Northern Trust
9
Northern Trust
Illinois
$1.64M – – –
PCMI
10
Princeton Capital Management Inc
New Jersey
$1.14M – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$764K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$754K – – –
RAM
13
Redmond Asset Management
Virginia
$749K – – –
TCIM
14
TIAA CREF Investment Management
New York
$676K – – –
BCM
15
Bridgeway Capital Management
Texas
$538K – – –
GS
16
Gagnon Securities
New York
$518K – – –
BIM
17
BlackRock Investment Management
Delaware
$479K – – –
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$352K – – –
CB
19
Commerce Bank
Missouri
$330K – – –
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$311K – – –
Morgan Stanley
21
Morgan Stanley
New York
$302K – – –
Adage Capital Partners
22
Adage Capital Partners
Massachusetts
$299K – – –
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$295K – – –
Group One Trading
24
Group One Trading
Illinois
$293K – – –
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$237K – – –
1
2 3 4

PSTV Hedge Fund Activity: Q2 2014 in Review

4 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2014, worth a combined $41.4M — up 3% from $40.2M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $6.73M. The largest seller was Allianz Asset Management, cutting an estimated $517K.

  • 4 institutional investors held Plus Therapeutics (PSTV) as of Q2 2014, up from 3 in Q1 2014.
  • Funds reported $41.4M of Plus Therapeutics stock for Q2 2014, up 3% quarter-over-quarter.
  • 1 fund opened new Plus Therapeutics positions in Q2 2014 and 0 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q2 2014 was Sabby Management, an estimated $6.73M added.
  • The largest Plus Therapeutics seller in Q2 2014 was Allianz Asset Management, an estimated $517K sold.

Based on aggregated 13F filings for Q2 2014.